Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW -0.79% shed 0.55% to $122.08 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.51% falling 0.46% to 4,493.28 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.74% falling 0.43% to 34,879.38. The stock's fall snapped a five-day winning streak. Edwards Lifesciences Corp. closed $1.19 below its 52-week high ($123.27), which the company achieved on September 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT -1.25% fell 1.29% to $133.43, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX -1.33% fell 0.22% to $45.41, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +1.44% fell 2.97% to $252.28. Trading volume (1.5 M) remained 550,329 below its 50-day average volume of 2.1 M.